jakedogman1,
Nice to see you come around. For a couple months there you were seeing "pipes" everywhere.
I agree with your statement today. I expect the data from the cancer patients in India to be very good, - enough for one or two or three pharma partnerships. (bavi/Docetaxel, bavi/Gemcitabine, bavi/Carboplatin/Paclitaxel).
MD Anderson would be a nice place to run the trials...
Also expecting bavi/ribavirin HCV trial, as well as bavi against HCV/HIV trial... soon :)
Ya know,
* HIV replicates WAAAAAAAY slower than HCV
* HIV infected cells (including those as-yet-impossible-to-deal-with latent HIV infected immune cells) expose PS.
j